The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer (Q40639142)

From Wikidata
Jump to navigation Jump to search
scientific article published on August 2003
edit
Language Label Description Also known as
English
The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer
scientific article published on August 2003

    Statements

    The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit